Integrated risk-benefit analyses: Method development with folic acid as example

Food and Chemical Toxicology

Volumn 46, Issue 3, 2008, Pages 893-909

  Hoekstra, Jeljer ^a   Verkaik Kloosterman, Janneke ^a   Rompelberg, Cathy ^a   van Kranen, Henk ^a   Zeilmaker, Marco ^a   Verhagen, Hans ^a   de Jong, Nynke ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

DALY; Folic acid; Quantification; Risk benefit; Simulation

Indexed keywords

FOLIC ACID;

ARTICLE; BREAD; CLINICAL TRIAL; COLORECTAL CANCER; CYANOCOBALAMIN DEFICIENCY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; FOOD ANALYSIS; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; MEGALOBLASTIC ANEMIA; METHODOLOGY; MORBIDITY; MORTALITY; NEURAL TUBE DEFECT; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; VITAMIN INTAKE;

ANEMIA, MEGALOBLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLIC ACID; FOOD, FORTIFIED; HUMANS; RISK ASSESSMENT;

EID: 38649122422     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.10.015     Document Type: Article

References (73)

1. Anonymous, 1998. Zo eet Nederland 1998. Resultaten van de Voedselconsumptiepeiling 1998. Den Haag: Voedingscentrum (in Dutch).
2. Anonymous, 2006. Rise in colorectal cancer to be stressed more clearly in folic acid fortification report. EU Food Law Online, vol. 281, p. 8.
3. Anthony, S., Kateman, H., Dorrepaal, C., Buitendijk, S., 2003. Aangeboren afwijkingen in Nederland 1996-2000. Gebaseerd op de landelijke verloskunde en neonatologie registraties. Report id. PG/JGD 2003.033, TNO, Leiden (in Dutch).
4. Arnesen T., and Kapiriri L. Can the value choices in DALYs influence global priority-setting?. Health Policy 70 (2004) 137-149
5. Bailey L.B. Dietary reference intakes for folate: the debut of dietary folate equivalents. Nutr. Rev. 56 (1998) 294-299
6. Bashir O., FitzGerald A.J., and Goodlad R.A. Both suboptimal and elevated vitamin intake increase intestinal neoplasia and alter crypt fission in the ApcMin/+ mouse. Carcinogenesis 25 (2004) 1507-1515
7. 12 deficiency and the fortification of food with folic acid. Eur. J. Clin. Nutr. 49 (1995) 787-793
8. Cohen J.T., Bellinger D.C., Connor W.E., Kris-Etherton P.M., Lawrence R.S., Savitz D.A., Shaywitz B.A., Teutsch S.M., and Gray G.M. A quantitative risk-benefit analysis of changes in population fish consumption. Am. J. Prev. Med. 29 (2005) 325-334
9. Cole, B.F., Baron, J.A., Sandler, R.S., Haile, R.W., Ahnen, D.J., Bresalier, R.S., McKeown-Eyssen, G., Summers, R.W., Rothstein, R., Burke, C.A., Snover, D.C., Church, T.R., Byers, T. A randomized trial of folic acid to prevent colorectal adenomas. In: AACR 96th Annual Meeting, April 16-20, 2005. American Association of Cancer Research Proceedings. 1041, abs #4399 (Abstract).
10. Coppens P., da Silva M.F., and Pettman S. European regulations on nutraceuticals, dietary supplements and functional foods: A framework based on safety. Toxicology 221 (2006) 59-74
11. Czeizel A.E., and Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327 (1992) 1832-1835
12. Daly L.E., Kirke P.N., Molloy A., Weir D.G., and Scott J.M. Folate levels and neural tube defects. Implications for prevention. JAMA 274 (1995) 1698-1702
13. 12 deficiency?. QJM 88 (1995) 357-364
14. Durga J., Verhoef P., Anteunis L.J., Schouten E., and Kok F.J. Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial. Ann. Int. Med. 146 (2007) 1-9
15. EFSA, 2006. Summary report EFSA scientific colloquium 6 - Risk-benefit analysis of foods: methods and approaches, 13-14 July 2006, Tabiano, Italy. Scientific colloquium series of the European Food safety authority.
16. Eichholzer M., Tonz O., and Zimmermann R. Folic acid: a public-health challenge. Lancet 367 (2006) 1352-1361
17. Ezzati M., Hoorn S.V., Rodgers A., Lopez A.D., Mathers C.D., and Murray C.J. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 362 (2003) 271-280
18. FAO/WHO Expert Consultation FAO/WHO Expert Consultation (Ed.), 1995. Application of risk analysis to food standards issues. Recommendations to the Codex Alimentarius Commission (ALINORM 95/9, Appendix 5) WHO, Geneva.
19. Farber S., Diamond L., Mercer R., Sylvester R., and Wolff J. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). N. Engl. J. Med. 238 (1948) 787-793
20. Finglas P.M., de Meer K., Molloy A., Verhoef P., Pietrzik K., Powers H.J., van der Straeten D., Jagerstad M., Varela-Moreiras G., van Vliet T., Havenaar R., Buttriss J., and Wright A.J. Research goals for folate and related B vitamin in Europe. Eur. J. Clin. Nutr. 60 (2006) 287-294
21. Fishman S.M., Christian P., and West K.P. The role of vitamins in the prevention and control of anaemia. Public Health Nutr. 3 (2000) 125-150
22. Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid - final rule. Fed. Regist. 61 (1996) 8781-8807
23. Foran J.A., Good D.H., Carpenter D.O., Hamilton M.C., Knuth B.A., and Schwager S.J. Quantitative analysis of the benefits and risks of consuming farmed and wild salmon. J. Nutr. 135 (2005) 2639-2643
24. 12 Publication no. 2000/21. Health Council of the Netherlands, The Hague (in Dutch).
25. Health Council of the Netherlands, 2003. Risks of folic acid fortification Publication no. 2003/04. Health Council of the Netherlands, The Hague (in Dutch).
26. Healton E.B., Savage D.G., Brust J.C., Garrett T.J., and Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 70 (1991) 229-245
27. Hoffbrand A.V., and Weir D.G. The history of folic acid. Br. J. Haematol. 113 (2001) 579-589
28. Honein M.A., Paulozzi L.J., Mathews T.J., Erickson J.D., and Wong L.Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285 (2001) 2981-2986
29. Institute of Medicine. Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (1998), National academy press, Washington, DC 196-305
30. Jansen M., Hulshof K., Konings E., and Brussaard T. Foliumzuur in Nederland: wat is de gebruikelijke inneming?. Voeding Nu 4 (2002) 25-29 (in Dutch)
31. Kim Y.I. Role of folate in colon cancer development and progression. J. Nutr. 133 (2003) 3731S-3739S
32. Kim Y.I. Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies. Environ. Mol. Mutagen. 44 (2004) 10-25
33. Kim Y.I., Salomon R.N., Graeme-Cook F., Choi S.W., Smith D.E., Dallal G.E., and Mason J.B. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39 (1996) 732-740
34. Kim D.H., Smith-Warner S.A., and Hunter D.J. Pooled analysis of prospective cohort studies on folate and colorectal cancer. Pooling project of diet and cancer investigators [abstract]. Am. J. Epidemiol. Suppl. 153 (2001) S118
35. Kloosterman, J., Bakker, M.I., De Jong, N., Ocké, M.C., 2007. Framework for intake simulation of functional ingredients. Public Health Nutrition, in press [e-pub ahead of print].
36. Kotsopoulos J., Medline A., Renlund R., Sohn K.J., Martin R., Hwang S.W., Lu S., Archer M.C., and Kim Y.I. Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis 26 (2005) 1603-1612
37. Lawrence M. Challenges in translating scientific evidence into mandatory food fortification policy: an antipodean case study of the folate-neural tube defect relationship. Public Health Nutr. 8 (2005) 1235-1241
38. Layrisse M., Roche M., and Baker S.J. Nutritional anaemias. Monogr Ser World Health Organ (1976) 55-82
39. Lin Y., Dueker S.R., Follett J.R., Fadel J.G., Arjomand A., Schneider P.D., Miller J.W., Green R., Buchholz B.A., Vogel J.S., Phair R.D., and Clifford A.J. Quantitation of in vivo human folate metabolism. Am. J. Clin. Nutr. 80 (2004) 680-691
40. Linden, M.W.v.d., Westert, G.P., Bakker, D.H.d., Schellevis, F.G., 2004. Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk: klachten en aandoeningen in de bevolking en in de huisartspraktijk. Report id. NIVEL W1.100. NIVEL, Rijksinstituut voor Volksgezondheid en Milieu, Utrecht, Bilthoven (in Dutch).
41. Meltzer H.M., Aro A., Andersen N.L., Koch B., and Alexander J. Risk analysis applied to food fortification. Public Health Nutr. 6 (2003) 281-291
42. 12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am. J. Clin. Nutr. 77 (2003) 1474-1477
43. Mozaffarian D., and Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296 (2006) 1885-1899
44. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338 (1991) 131-137
45. Murray C.J., and Acharya A.K. Understanding DALYs (disability-adjusted life years). J. Health Econ. 16 (1997) 703-730
46. Murray, C.J., Lopez, A.D., 1996. The Global Burden of Disease: A Comparative Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard School of Public Health, on behalf of the WHO and the World Bank, Cambridge, MA.
47. Murray C.J., and Lopez A.D. Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ. 9 (2000) 69-82
48. NEVO Foundation, 2001. NEVO table 2001, Dutch Food Composition Database. Netherlands Bureau for Nutrition Education, The Hague.
49. Nusser S., Carriquiry A., Dodd K., and Fuller W. A semiparametric transformation approach to estimating usual daily intake distributions. J. Am. Stat. Assoc. 91 (1996) 1440-1449
50. Ocké, M.C., Buurma-Rethans, E.J.M., Fransen, H.P., 2005. Dietary supplement use in the Netherlands. Current data and recommendations for future assessment Report no. 350100001/2005. RIVM, Bilthoven.
51. Paalman M., Bekedam H., Hawken L., and Nyheim D. A critical review of priority setting in the health sector: the methodology of the 1993 World Development Report. Health Policy Plan 13 (1998) 13-31
52. Ponce R.A., Bartell S.M., Wong E.Y., LaFlamme D., Carrington C., Lee R.C., Patrick D.L., Faustman E.M., and Bolger M. Use of quality-adjusted life year weights with dose-response models for public health decisions: a case study of the risks and benefits of fish consumption. Risk Anal. 20 (2000) 529-542
53. Ponce R.A., Wong E.Y., and Faustman E.M. Quality adjusted life years (QALYs) and dose-response models in environmental health policy analysis - methodological considerations. Sci. Total Environ. 274 (2001) 79-91
54. Ray J.G., Meier C., Vermeulen M.J., Boss S., Wyatt P.R., and Cole D.E. Association of neural tube defects and folic acid food fortification in Canada. Lancet 360 (2002) 2047-2048
55. Renwick A.G., Flynn A., Fletcher R.J., Muller D.J., Tuijtelaars S., and Verhagen H. Risk-benefit analysis of micronutrients. Food Chem. Toxicol. 42 (2004) 1903-1922
56. Rompelberg, C.J.M., Jager, M., Bakker, M.I., Buurma-Rethans, E.J.M., Ocké, M.C. 2006. Functional food monitoring as part of the new Dutch dietary monitoring system Report no. 350100002. RIVM, Bilthoven.
57. Ryan B.M., and Weir D.G. Relevance of folate metabolism in the pathogenesis of colorectal cancer. J. Lab. Clin. Med. 138 (2001) 164-176
58. Sanjoaquin M.A., Allen N., Couto E., Roddam A.W., and Key T.J. Folate intake and colorectal cancer risk: a meta-analytical approach. Int. J. Cancer 113 (2004) 825-828
59. Scientific Committee on Food, 2000. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Folate Report id. SCF/CS/NUT/UPPLEV/18 Final. European Commission, health & consumer protection directorate-general, Brussels.
60. Scientific Steering Committee, 2000. First report on the harmonisation of risk assessment procedures. Part I. The report of the Scientific Steering Committee's Working Group on Harmonisation of Risk Assessment Procedures in the Scientific Committees Advising the European Commission in the Area of Human and Environmental Health. Part 2. Appendices, (published in the internet on 20 December 2000) European Commission, Brussels.
61. 6. In: Stipanuk M.H. (Ed). Biochemical and Physiological Aspects of Human Nutrition (2000), WB Saunders Company, Philadelphia 483-518
62. Statistics Netherlands, 2007. StatLine [database on the Internet, URL: www.cbs.nl]. Statistics Netherlands, Voorburg/Heerlen.
63. Stouthard, M.E.A., Essink-Bot, M.-L., Bonsel, G.J., Barendregt, J.J., Kramers, P.G.N., van de Water, H.P.A., Gunning-Schepers, L.J., van der Maas, P.J., 1997. Disability weights for diseases in The Netherlands, Rotterdam: Department of Public Health, Erasmus University Rotterdam.
64. Streiff R.R. Folic acid deficiency anemia. Semin. Hematol. 7 (1970) 23-39
65. Suitor C.W., and Bailey L.B. Dietary folate equivalents: interpretation and application. J. Am. Diet. Assoc. 100 (2000) 88-94
66. Tucker K.L., Mahnken B., Wilson P.W., Jacques P., and Selhub J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. JAMA 276 (1996) 1879-1885
67. Ulrich C.M., and Potter J.D. Folate supplementation: too much of a good thing?. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 189-193
68. van Kreijl, C.F., Knaap, A.G.A.C., van Raaij, J.M.A., 2006. Our food, Our Health: Healthy Diet and Safe Food in The Netherlands, first ed. National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
69. Visser O., and van Leeuwen F.E. Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands. Eur. J. Cancer 41 (2005) 2321-2330
70. Wald N.J., Law M.R., Morris J.K., and Wald D.S. Quantifying the effect of folic acid. Lancet 358 (2001) 2069-2073
71. WHO, 2003. Diet, nutrition and the prevention of chronic diseases. Report of a Joint WHA/FAO Expert Consultation Technical Report Series 916. World Health Organisation, Geneva.
72. Williams L.J., Mai C.T., Edmonds L.D., Shaw G.M., Kirby R.S., Hobbs C.A., Sever L.E., Miller L.A., Meaney F.J., and Levitt M. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66 (2002) 33-39
73. Wong E.Y., Ponce R.A., Farrow S., Bartell S.M., Lee R.C., and Faustman E.M. Comparative risk and policy analysis in environmental health. Risk Anal. 23 (2003) 1337-1349